posted April 13, 2022 02:52 am by Whitman19
(4)
The next couple of catalysts include the toxicology study for 5HT2A to treat MDD/TRD and the Phase-1 clinical trials for BMB-101 to treat Alzheimer's. Both are likely to start this quarter
rate and reply
posted March 25, 2022 02:59 am by Whitman19
(4)
That's wonderful. Just waiting for the stock to take off
rate and reply
posted March 14, 2022 07:55 am by AwareInvestor
(542)
Drug development continues for the Bright Minds Biosciences lead product. The firm this morning published positive results from a recent 28-day toxicity study conducted on its novel formulation, BMB
...read more
posted January 10, 2022 02:33 am by Whitman19
(4)
Unlike most biotechs developing drugs from naturally occurring psychedelics, Bright Minds is creating novel compounds that retain the therapeutic benefits of psychedelics while minimising side effects
...read more
posted December 29, 2021 11:23 am by Whitman19
(4)
"I would say we have the largest and most advanced psychedelic drug discovery program in the history of the world. That’s over 25 chemists working around the clock developing completely novel
...read more
posted December 02, 2021 01:16 am by Whitman19
(4)
Bright Minds has a portfolio of three patented mechanisms based on serotonin (5-HT) receptors, assessed for indications ranging from depression to chronic pain. The firm also has "
...read more
posted November 03, 2021 10:15 am by Whitman19
(4)
This is one of the best news for the psychedelic sector in a long time...Way to go BM
rate and reply
posted November 03, 2021 08:51 am by AwareInvestor
(542)
There’s another Canadian firm set to trade on the Nasdaq market. Bright Minds Bioscience this morning announced that it has been approved to begin trading on the major big board exchange. https
...read more
posted October 13, 2021 01:00 pm by amichael
(1)
Watch Dr Gideo Shapira, VP of discovery discuss the recent, upcoming events at Bright Minds Biosciences and how the success of other firms like Compass Pathways could positively impact the entire
...read more
posted October 06, 2021 12:39 pm by amichael
(1)
Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric
...read more
posted October 05, 2021 07:16 am by Whitman19
(4)
Watch Ian McDonald, CEO of Bright Minds Biosciences' interview with James Hallifax- Psychedelic Investor YouTube Channel https://www.youtube.com/watch?v=g6BAYc-TsGU
rate and reply
posted October 04, 2021 01:52 pm by Whitman19
(4)
Bright Minds looks all set to begin clinical trials on their New Chemical Entity (NCE), BMB-101 sometime in Q1 2022. That's gonna be a big relief to patients suffering from Dravet syndrome, opioid
...read more
posted August 18, 2021 08:55 am by AwareInvestor
(542)
Bright Minds Biosciences this morning announced preliminary results from an ongoing study being conducted by the firm. The company has seen efficacy in rodent models of Dravet Syndrome, a form of
...read more
posted July 26, 2021 01:57 pm by amichael
(1)
Watch Brom from theintegrationcompany interview Ian McDonald & Gideon Shapiro https://www.youtube.com/watch?v=SJn032nz2F0Enable GingerCannot connect to Ginger Check your internet connection
...read more
posted July 06, 2021 06:10 am by Whitman19
(4)
Here's an amazing research report from Colin Sullivan making the case for Bright Minds Biosciences, the market size for their drugs, estimated total free and discounted cash flow, NPV and risks
...read more
posted July 01, 2021 11:43 am by Whitman19
(4)
Brom is interviewing Bright Minds CEO Ian McDonald and VP of Discovery Dr. Gideon Shapiro on his podcast, "The Integration Conversation" today. The podcast /youtube channel features the
...read more
posted June 29, 2021 02:50 pm by amichael
(1)
Emerita Resources EMO Bright Minds Biosciences DRUG Deep South Resources DSM Cross River Ventures CRVC For additional info, lookup https://www.paradigmresearch.ca/campaigns/view-campaign
...read more
posted June 24, 2021 12:38 pm by Whitman19
(4)
Watch this very informative video to know more about the various serotonin receptors, what causes neurological disorders and how Bright Minds Biosciences (CSE: DRUG, OTCQB: BMBIF) is at the forefront
...read more
posted June 21, 2021 04:10 am by Whitman19
(4)
I'm buying on every decline and hope to have at least 2k shares before they uplist
rate and reply